Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 6

1.

Randomized comparison of biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents for percutaneous coronary revascularization: rationale and design of the BIOSCIENCE trial.

Pilgrim T, Roffi M, Tüller D, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Heg D, Jüni P, Windecker S.

Am Heart J. 2014 Sep;168(3):256-61. doi: 10.1016/j.ahj.2014.06.004. Epub 2014 Jun 6.

PMID:
25173535
2.

Current application and bioavailability of drug-eluting stents.

Escárcega RO, Baker NC, Lipinski MJ, Magalhaes MA, Minha S, Omar AF, Torguson R, Waksman R.

Expert Opin Drug Deliv. 2014 May;11(5):689-709. doi: 10.1517/17425247.2014.888054. Epub 2014 Feb 17. Review.

PMID:
24533457
3.

A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.

Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, Costa JR Jr, Chamie D, Abizaid AS, Pinto I, Morrison L, Toyloy S, Bhat V, Yan J, Abizaid A.

JACC Cardiovasc Interv. 2014 Jan;7(1):89-99. doi: 10.1016/j.jcin.2013.07.007. Epub 2013 Oct 16.

4.

Stent thrombosis: an overview.

Centemero MP, Stadler JR.

Expert Rev Cardiovasc Ther. 2012 May;10(5):599-615. doi: 10.1586/erc.12.38. Review.

PMID:
22651836
5.

Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.

Waksman R, Pakala R.

EuroIntervention. 2009 Dec 15;5 Suppl F:F36-42. doi: 10.4244/EIJV5IFA6. Review.

PMID:
22100674
6.

Fully biodegradable coronary stents : progress to date.

Ramcharitar S, Serruys PW.

Am J Cardiovasc Drugs. 2008;8(5):305-14. Review.

PMID:
18828642
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk